drug

QT-019B

Phase 2updated 3mo ago

by Hangzhou Qihan Biotechnology Co Ltd

Phase 2

community read0 votes

indications

Lupus

all catalysts(0)

nothing on the calendar yet

Trials studying QT-019B

phase1A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosusrecruitingn=18

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 6m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

QT-019B

Phase 2updated 3mo ago

by Hangzhou Qihan Biotechnology Co Ltd

Phase 2

community read0 votes

indications

Lupus

all catalysts(0)

nothing on the calendar yet

Trials studying QT-019B

phase1A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosusrecruitingn=18

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 6m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

QT-019B

indications

all catalysts(0)

Trials studying QT-019B

News(0)

Report a data issue

comments(0)

QT-019B

indications

all catalysts(0)

Trials studying QT-019B

News(0)

Report a data issue

comments(0)